$4.14
$0.00 (0.00%)
End-of-day quote: 05/18/2024
ASX:CU6
Clarity Pharmaceuticals Ltd Annual Report
| Year | Year | 2023 | 2022 | ||
|---|---|---|---|---|---|
| Rev. | Revenue |
|
$9.80M | $6.46M | |
| GM % | Gross Margin % |
|
100.00% | 100.00% | |
| OM | Operating Margin |
|
-269.00% | -263.94% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.10 | $-0.09 |
| Div. | Dividends |
|
$0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | 0 | |
| Sha. | Shares |
|
260.66m | 257.94m | |
| OCF | Operating Cash Flow |
|
$-27.50M | $-13.31M | |
| FCF | Free Cash Flow |
|
$-27.55M | $-13.53M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.11 | $-0.05 |
